pharma · Asthma · Multiple Sclerosis · TEVA
Teva Pharma
Teva Pharma GmbH
Teva Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- 10 Dornierstr., Ulm, Donau, 89079, DE, TEL AVIV
- Employees
- 126
- Programs
- 7
- Drugs
- 407
- Patents
- 185
Teva Pharma clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Teva Pharma programs — each row shows trial ID, program name, phase, status, and indication.
Teva Pharma trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Teva Pharma.
-
Talampanel — Phase 2
Clinical update -
Fremanezumab — Phase 2
Clinical update -
armodafinil — Phase 2
Clinical update -
Oral CEP-701 — Phase 2
Clinical update -
TV-44749 — Phase 3
Clinical update -
TEV-53408 — Phase 1
Clinical update -
TL011 — Phase 1
Clinical update -
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
Patent grant